HTAi 2021 LAPF

Mrs. Ali Powers Participants | Participantes Events Manager HTAi [email protected] Alicia (known as Ali) is an event organizer with Alicia (conocida como Ali) es una organizadora over 15 years of experience in every aspect de eventos con más de 15 años de experiencia en of events management, including large and todos los aspectos de la gestión de eventos, incluida small conference management in national and la gestión de conferencias grandes y pequeñas en international locations, workshop development, ubicaciones nacionales e internacionales, desarrollo and annual gala productions. Ali’s experience de talleres y producciones de gala anuales. La also includes event work with professional sports experiencia de Ali también incluye el trabajo en teams, universities, hospital foundations, and eventos con equipos deportivos profesionales, health technology startup organizations. Before universidades, fundaciones hospitalarias y joining HTAi, Ali held a position in the Corporate organizaciones emergentes de tecnología de la Communications and Marketing department at salud. Antes de unirse a HTAi, Ali ocupó un puesto Alberta Innovates. She has also executed over 60 en el departamento de marketing y comunicaciones weddings over the past decade and was recently corporativas de Alberta Innovates. También ha shortlisted in the “future leader” category at the realizado más de 60 bodas durante la última Edmonton Event Awards. Ali also sits on the Board década y recientemente fue preseleccionada en la of Directors for the International Live Events categoría de \"líder futuro\" en los premios Edmonton Association (ILEA – Edmonton Chapter). Event Awards. Ali también forma parte de la Junta Directiva de la Asociación Internacional de Eventos en Vivo (ILEA - Capítulo de Edmonton). 99

Participants | Participantes Andrea Rappagliosi Vice-President, Market Access, Public Affairs and Communications EMEA, Canada and LATAM Edwards LifeSciences [email protected] A_Rappagliosi www.linkedin.com/in/rappagliosi Andrea Rappagliosi Andrea is currently Vice- Andrea Rappagliosi Andrea is currently Vice- President Market Access, Public Affairs and President Market Access, Public Affairs and Communication EMEA, Canada and LATAM at Communication EMEA, Canada and LATAM at Edwards Lifesciences. Born in Rome, Andrea Edwards Lifesciences. Born in Rome, Andrea received a law degree from the University of Rome received a law degree from the University of Rome “La Sapienza”. Andrea began his professional “La Sapienza”. Andrea began his professional career in the Italian Senate. Recently he worked career in the Italian Senate. Recently he worked in the Sanofi group as VP Public Affairs Europe in the Sanofi group as VP Public Affairs Europe and before as VP, Market Access, Health Policy and and before as VP, Market Access, Health Policy and Medical Affairs at Sanofi Pasteur MSD. At SPMSD Medical Affairs at Sanofi Pasteur MSD. At SPMSD Joint Venture he was member of its Executive Joint Venture he was member of its Executive Committee from 2012 to 2016. Before, he worked Committee from 2012 to 2016. Before, he worked at Baxter Healthcare, Serono International and GSK at Baxter Healthcare, Serono International and GSK in different European and International positions in different European and International positions in the public affairs and market access policy in the public affairs and market access policy area. In the last ten years, Andrea represented area. In the last ten years, Andrea represented the healthcare Industry in several European EU the healthcare Industry in several European EU Commission and Member States initiatives such Commission and Member States initiatives such as as the HTANetwork, EUnetHTA Joint-Action 3, the HTANetwork, EUnetHTA Joint-Action 3, and the and the EU Active & Healthy Aging Innovation EU Active & Healthy Aging Innovation Partnership. Partnership. Andrea is a founding member of the Andrea is a founding member of the HTAi Policy HTAi Policy Forum. He was President of EuropaBio Forum. He was President of EuropaBio the European the European Association of the biotech Industry Association of the biotech Industry (2009-2011), (2009-2011), and of Vaccines Europe, the European and of Vaccines Europe, the European Vaccines Vaccines manufacturers association (2013- manufacturers association (2013-2017). Andrea was 2017). Andrea was member of the High-Level member of the High-Level Pharmaceutical Forum Pharmaceutical Forum (2005-2008). (2005-2008). 100

Medico - Cirujano Nora Reyes Puma Participants | Participantes Responsable De La Unidad De Análisis Y Generación De Evidencias En Salud Pública Unagesp- ins Instituto Nacional de Salud [email protected] www.facebook.com/unagesp.ins Surgeon with a master's degree in Public Health Medico Cirujano con maestria en Salud Publica y and a doctorate in Medicine, I have worked in doctorado en Medicina, he trabajado en diferentes different positions in the health system of my posiciones en el sistema de salud de mi pais country from primary care to the ministry of desde la atención primaria, hasta el ministerio de health, I work at the National Institute of Health salud, me desempeño en el Instituto Nacional de currently in charge of the Unit of Analysis and Salud actualmete a cargo de la Unidad de Analisis Generation of Evidence in Public Health. Our y Generación de Evidencias en Salud Pública. institution performs STDs in public health and Nuestra institución realiza ETS de salud publica y currently also in individual health. Professor at the actualmente tambien en salud individual. Docente Universidad Nacional Mayor de San Marcos and de la Universidad Nacional Mayor de San Marcos our main interest is to help make better decisions y nuestro principal interes es ayudar a que se in the use of health resources. tomen mejores decisiones en el uso de los recursos sanitarios. Adriana Robayo Executive Director IETS - Instituto de Evaluación Tecnológica en Salud [email protected] amrobayog Adriana M. Robayo G MD FETP 101

Participants | Participantes Ms. Cecilia Rodríguez Directora Ejecutiva Fundación Me Muevo [email protected] memuevocl www.facebook.com/memuevo.cl www.linkedin.com/company/memuevo-org www.instagram.com/memuevocl/ Social Communicator, Executive Director Comunicadora Social, Directora Ejecutiva de at Fundación Me Muevo whose purpose is Fundación Me Muevo que tiene como propósito to cultivate citizen participation in health. cultivar la participación ciudadana en salud. Coordinator in citizen efforts for social incidence, Coordinadora en gestiones ciudadanas de knowledge, education and citizen participation incidencia social, conocimiento, educación y in public health. Activist for the representation of participación ciudadana en salud pública. Activista patients, self-care and people-centered health. por la representación de pacientes, autocuidado y salud centrada en las personas. Mrs. Gabriela R. Rodriguez Grimalt Administrative Assistant IECS [email protected] Gabriela Rodriguez Professor affiliated to Associate Gabriela Rodriguez Profesora adscrita a Profesores Professors Graduated from the Teacher Training Asociados Egresados del Instituto Superior del Institute Lenguas Vivas \"Juan Ramón Fernández\" Profesorado en Lenguas Vivas “Juan Ramón (PAELV), Law student at University of Buenos Aires Fernández” (PAELV), estudiante de Derecho en la (UBA) and Teacher Training in Technical English Universidad de Buenos Aires (UBA) y estudiante student at National Technological University - del Profesorado Técnico de Inglés en la Universidad Argentina (UTN). Gabriela is the Health Technology Tecnológica Argentina (UTN). Gabriela es Assessment and Health Economics Administrative Coordinadora Administrativa del Departamento de Department Assistant of the Institute for Clinical Evaluación de Tecnologías Sanitarias y Economía Effectiveness and Health Policy (IECS), having de la Salud del Instituto de Efectividad Clínica previously served in the administrative and y Sanitaria (IECS), habiéndose desempeñado commercial areas of important multinational previamente en el área administrativa y comercial companies. en importantes empresas multinacionales. 102

Mr. Nicola Romanello Participants | Participantes Pfizer [email protected] Nicola is the current director of PHI (patient health Nicola is the current director of PHI (patient health and impact) at Pfizer for a cluster formed by Chile, and impact) at Pfizer for a cluster formed by Chile, Perú, Ecuador and Bolivia. The area oversees Perú, Ecuador and Bolivia. The area oversees the the market access cross-functional process, market access cross-functional process, being being responsible for HEOR, pricing, and patient responsible for HEOR, pricing, and patient support support programs. We engage with external programs. We engage with external stakeholders stakeholders with the objective to improve access with the objective to improve access for patients in for patients in an equitable way while promoting an equitable way while promoting the sustainability the sustainability of the healthcare systems we of the healthcare systems we interact with. interact with. Main focus of work has been on Main focus of work has been on transforming transforming organizations to improve market organizations to improve market access capabilities, access capabilities, driving patient centric culture driving patient centric culture and innovation and innovation in the industry relationship in the industry relationship with payers through with payers through innovative agreements. He innovative agreements. He has previously hold has previously hold positions across different positions across different industries, countries, industries, countries, and functions with focus on and functions with focus on the healthcare and the healthcare and pharmaceutical industry. Italian pharmaceutical industry. Italian citizen living citizen living in Brazil / Chile, Nicola holds an MBA in Brazil / Chile, Nicola holds an MBA from IESE from IESE Business School, other degrees from Business School, other degrees from EADA, EDHEC, EADA, EDHEC, and Padua University with focus on and Padua University with focus on management management and political sciences. and political sciences. Dr. Ricardo Ruano Arévalo Director De Tecnologías Sanitarias Ministerio De Salud De El Salvador [email protected] rickruano23 www.linkedin.com/in/ricardo-humberto-ruano-ar%C3%A9valo-22419a163/ I am a doctor by profession, graduated from the Soy medico de profesión, graduado de la University of El Salvador, master in Public Health Universidad de El Salvador, maestro en Salud and postgraduate degrees in health economics Pública y posgrados en economía de la salud y en and in Health Technology Assessment. Currently, I evaluación de Tecnologías Sanitarias. Actualmente work as Director of Health Technologies, previously trabajo como Director de Tecnologías Sanitarias, I coordinated the Health Technology Assessment anteriormente coordinaba la Unidad de Evaluación Unit. I am part of the Development Group of de Tecnologías Sanitarias. Soy parte del Grupo Guides based on evidence according to the GRADE Desarrollador de Guías basada en la evidencia methodology by the National Institute of Health of según metodología GRADE por parte del Instituto the Country. Nacional de Salud del País. 103

Participants | Participantes Dra. Ana Eduviges Sancho Jiménez Jefe Unidad De Tecnologías En Salud Ministerio de Salud [email protected] Head of the Unit of Health Technologies in the Jefe de la Unidad de Tecnologías en Salud en la Health Research and Technologies Directorate Dirección de Investigación y Tecnologías en Salud at Ministry of Health of Costa Rica. She is del Ministerio de Salud de Costa Rica. Enlace del the country's link to the Health Technology país ante la Red de Evaluación de Tecnologías Assessment Network of the Americas (RedETSA). Sanitarias de las Américas (RedETSA). Cuenta She has more than 28 years of professional con más de 28 años de experiencia profesional e and investigative experience in the field of investigativa en el campo de la salud pública. Ha public health. She has participated in various participado en diversas investigaciones y estudios investigations and studies at the national level a nivel nacional en su planificación, ejecución y in their planning, execution and analysis and análisis y cuenta con diversas publicaciones en el has several publications on the subject of the tema de las investigaciones mencionadas. mentioned researchs. 104

Mr. Dino Sepulveda Participants | Participantes Head Of Health Technology Assessment Department Ministry Of Health [email protected] deeno87 www.linkedin.com/in/dinosv/ Dino Sepúlveda is a doctor in medicine, with an Dino Sepúlveda Viveros es Médico Cirujano, M.Sc. in Health Management and a postgraduate Magíster en Gestión en Salud y Diplomado en diploma in Contemporary State Intelligence. Inteligencia del Estado Contemporáneo. Ha Has worked in infection control and clinical trabajado en epidemiología clínica y control epidemiology and as legislative assistant in de infecciones. Desde el año 2016 dirige el the Senate of Chile. Since 2016, he has led the Departamento de Evaluación de Tecnologías Department of Health Technology Assessment Sanitarias y Salud Basada en Evidencia, liderando and Evidence-Based Medicine. Has guided the la implementación de la metodología GRADE implementation of GRADE methodology in the en la elaboración de Guías de Práctica Clínica en development of Clinical Practice Guidelines in Chile, así como el primer proceso sistemático de Chile, and also leading the first systematic process Evaluación de Tecnologías Sanitarias en Chile, a of Health Technology Assessment in Chile, through través de la Ley de Diagnósticos y Tratamientos the law of High-Cost Medicines and Diagnosis de Alto Costo “Ricarte Soto”. Sus intereses de “Ricarte Soto”. Has been appointed Executive desarrollo e investigación están centrados en el uso Secretary of the Ministerial Advisory Commission de evidencia para la toma de decisiones, así como on Rare Diseases. His interests in development en el desarrollo de metodologías de priorización and research are the use of evidence for decision en salud y enfermedades raras. A partir del año making and development of prioritisation 2019 fue nombrado como Secretario Ejecutivo de methodologies in health and rare diseases. He is la Comisión Asesora Ministerial de Enfermedades research collaborator of the Global Health Program Raras y Poco Frecuentes. Es además investigador at Universidad de Chile. colaborador del Programa de Salud Global de la Universidad de Chile. Sra Yaniris Silva Biomarin [email protected] 105

Participants | Participantes Mr. Jose Thomaz Mkt Access Latam Director Biomarin [email protected] www.linkedin.com/in/josé-carlos-thomaz-junior-b9b00721 José Carlos Thomaz Junior. Mechanical Engineer José Carlos Thomaz Junior. Ingeniero Mecánico de from Universidade de São Paulo (São Paulo, Brazil), la Universidade de São Paulo (São Paulo, Brasil), con with master degree in Aeronautic Engineering maestría en Ingeniería Aeronáutica del Instituto from Instituto Tecnologico da Aeronautica (São Tecnologico da Aeronautica (São Paulo, Brasil). Paulo, Brazil). MBA from The Wharton School MBA de The Wharton School of Business (Filadelfia, of Business (Philadelphia, USA) and Master in EE. UU.) Y Máster en Estudios Internacionales del International Studies from The Lauder Institute Instituto Lauder de la Universidad de Pensilvania from University of Pennsylvania (Philadelphia, (Filadelfia, EE. UU.). Actualmente director de USA). Currently director of Market Access LATAM Market Access LATAM para BioMarin desde 2020. for BioMarin since 2020. Previously repsonsible Anteriormente fue responsable de Estrategia for Business Strategy and Operations from 2017 y Operaciones de Negocios de 2017 a 2020 en to 2020 at the same company. Prior to BioMarin, la misma empresa. Antes de BioMarin, trabajó he worked at Sanofi Brazil from 2014 to 2017, as en Sanofi Brasil de 2014 a 2017, como jefe de head of different functions, including: Patients and diferentes funciones, que incluyen: relaciones con Clients relations, SFE, Strategic Planning and Chief pacientes y clientes, SFE, planificación estratégica of Staff. Prior to entering to the pharmaceutical y jefe de personal. Antes de ingresar a la industria industry, he worked as an Aeroautic Engineer and farmacéutica, se desempeñó como ingeniero Strategic consultant. aeronáutico y consultor estratégico. Mr. Santiago Torales Director De Investigación En Salud Ministerio De Salud, Argentina [email protected] Medical Doctor (Catholic University of Córdoba, Médico (Universidad Católica de Córdoba, Argentina). Nephrology Specialist - Master and Argentina). Especialista en Nefrología - Magíster Specialist in Health Economics and Management y Especialista en Economía y Gestión de la Salud (ISALUD University, Argentina). Researcher and (Universidad ISALUD, Argentina). Investigador Professor in Clinical Effectiveness and Economic y Docente en Efectividad Clínica y Evaluaciones Evaluations in Health at the National University Económicas en Salud en la Universidad Nacional del of the Litoral (Santa Fe, Argentina); Advisor in Litoral (Santa Fe, Argentina), Asesor en coberturas coverage for public and private health programs y programas públicos y privados de salud y and high-cost access; and Temporary Consultant acceso en alto costo y Consultor Temporario de la of the Pan American Health Organization ( Chronic Organización Panamericana de la Salud (Proyecto Kidney Disease Project) He is currently Director Enfermedad Renal Crónica) Actualmente es Director of Health Research (DIS) and General Supervisor de Investigación en Salud (DIS) y Supervisor of the National Commission for the Evaluation General de la Comisión Nacional de Evaluación of Health Technologies (CONETEC), both in the de Tecnologías Sanitarias (CONETEC) ambas en el Ministry of Health (Argentina) Ministerio de Salud de la Nación (Argentina). 106

Mr. Juan Valencia Participants | Participantes Sr Director Medtronic [email protected] Senior health economist and medical doctor Economista senior de salud y médico con educación with advanced education and experience in avanzada y experiencia en asuntos de salud public health matters and the design, creation, pública y el diseño, creación y ejecución de planes and execution of transformative market access transformadores de acceso al mercado. Distinguida plans. Distinguished history of leadership in the trayectoria de liderazgo en el análisis económico economic analysis and commercialization of y comercialización de terapias de vanguardia. cutting-edge therapies. Actually Senior Director Actualmente es Director Senior de Economía de Health Economics, Policy an Reimbursement at la Salud, Política y Reembolso en Medtronic Latin Medtronic Latin America America EDUCATION EDUCACIÓN • Medical Doctor and Surgeon. CES Medical • Médico y Cirujano. Escuela de Medicina CES School • Especialista en Salud Ocupacional. Especialista • Specialist in Occupational Health. CES Medical en Economía de la Salud de la Facultad de School Specialist in Health Economics. CES Medicina del CES. Escuela de Medicina CES Medical School • Profesor de la Universidad CES • Professor at CES University • Beca en Economía de la Salud, Universidad • Fellowship in Health Economics, Valencia Politécnica de Valencia, España. Polytechnic University, Spain. • Beca en Economía de la Salud, Escuela de • Fellowship in Health Economics, Robert Wood Medicina Robert Wood Johnson, Nueva Jersey. Johnson Medical School, New Jersey. • Programa de maestría en Seguridad Social, • Master program of Social Security, Leuven Universidad Católica de Lovaina, Bélgica Catholic University, Belgium 107

Participants | Participantes Dr. Joice Valentim HTA Strategy Lead F. Hoffmann-La Roche [email protected] www.linkedin.com/in/joicevalentim-phd/ Joice Valentim is Global HTA Strategy Lead, and (spanish) Joice Valentim es Líder Global de prior Global Access Evidence Lead and Latin Estrategia de HTA, y anteriormente Líder de America HTA Lead, at Roche Pharma. Joice is Evidencia de Acceso Global y Líder de HTA para responsible for the Global HTA Strategy, leading América Latina, en Roche Pharma. Joice es the organization towards an unified HTA position responsable de la estrategia global de ETS, lo que to partner with stakeholders for early, holistic lleva a la organización hacia una posición unificada and deliberative HTA, locally appropriate and de ETS para asociarse con las partes interesadas innovation-ready. Joice represents Roche at efpia, para una ETS temprana, holística y deliberativa, CIRS, PhRMA, and HTAi, and for academia. For HTAi, localmente apropiada y lista para la innovación. currently collaborating with the HTAi GPF and Joice representa a Roche en efpia, CIRS, PhRMA HTAi Annual Meeting committees. Before, in the y HTAi, y para el mundo académico. Para HTAi, HTAi LA PF committee, ISPOR Industry Committee colaborando actualmente con los comités de la as LA president, and FIFARMA. She was an invited Reunión Anual de HTAi GPF y HTAi. Antes, en el professor at the University of São Paulo (MBA HTA, comité de HTAi LA PF, el Comité de Industria de Health Economics/FIPE), a reviewer of scientific ISPOR como presidente de LA, y FIFARMA. Fue journals and author of articles and abstracts profesora invitada de la Universidad de São Paulo on HTA and HE. Prior to Roche, she worked at (MBA HTA, Economía de la Salud / FIPE), revisora ​d​ e Novartis, and universities in Brazil as professor revistas científicas y autora de artículos y resúmenes and researcher, including projects for the Ministry sobre ETS y ES. Antes de Roche, trabajó en of Health (HTA for inclusion of new vaccines into Novartis y universidades en Brasil como profesora e the National Immunization Program/PNI) and the investigadora, incluidos proyectos para el Ministerio National Regulatory Agency for Private Health de Salud (HTA para la inclusión de nuevas vacunas Insurance and Plans (ANS) of Brazil, PAHO, IDB and en el Programa Nacional de Inmunización / PNI) the World Bank. Economist, Joice holds a master y la Agencia Nacional Reguladora de Seguros de degree in Economics and a doctorate degree in Salud Privados y Planes (ANS) de Brasil, OPS, BID Preventive Medicine from the University of São y Banco Mundial. Economista, Joice tiene una Paulo. For more information please visit: http:// maestría en Economía y un doctorado en Medicina buscatextual.cnpq.br/buscatextual/visualizacv. Preventiva de la Universidad de São Paulo. Para do?id=K4706373D5&idiomaExibicao=2 mayor información por favor visite: http:// buscatextual.cnpq.br/buscatextual/visualizacv. do?id=K4706373D5&idiomaExibicao=2 108

Victoria Wurcel Participants | Participantes Regional Director Outcomes Research Oncology MSD [email protected] Director Outcomes Research Oncology CORE Director Outcomes Research Oncology CORE Latin America at MSD. Medical Doctor, MSc in Latin America at MSD. Medical Doctor, MSc in Clinical Effectiveness and Public Health, Health Clinical Effectiveness and Public Health, Health Economics and Health Technology Assessment Economics and Health Technology Assessment Specialist.Former Associate Director Health Specialist.Former Associate Director Health Economics MSD Argentina, oncology focus. 2020 Economics MSD Argentina, oncology focus. 2020 Onco Market Access Regional Assignment & Onco Market Access Regional Assignment & Star Award Winner for health economic project. Star Award Winner for health economic project. Over 12 years-experience (gov´ and industry Over 12 years-experience (gov´ and industry in LA & EU) researching, executing & teaching in LA & EU) researching, executing & teaching health economics, health technology assessment health economics, health technology assessment and outcome research studies applied to and outcome research studies applied to pharmaceuticals, medical devices and diagnostic pharmaceuticals, medical devices and diagnostic technologies. Market Access, Economic Policy and technologies. Market Access, Economic Policy and Public Affairs experience. Redetsa, RedArets & Public Affairs experience. Redetsa, RedArets & int´VODI platform founding Member. Rep. before int´VODI platform founding Member. Rep. before INAHTA, Mercosur. EU Commission & EUnetHTA. INAHTA, Mercosur. EU Commission & EUnetHTA. ISPOR & HTAi Member. Former editor of peer ISPOR & HTAi Member. Former editor of peer reviewed journal ¨Evidencia¨ & reviewer for IJHTAi; reviewed journal ¨Evidencia¨ & reviewer for IJHTAi; Brazilian HTA Network & Argentinian Journal of Brazilian HTA Network & Argentinian Journal of Public Health. Public Health. 109

HTAi 2022 ANNUAL MEETING UTRECHT, NETHERLANDS Lifecycle Approach: Coming Together to Make it Happen HTAi invites you to join the leading minds in Health Technology Assessment (HTA) from around the world to discuss and debate the lifecycle approach in HTA in this year’s Annual Meeting. The 2022 Annual Meeting will o er a global platform to deepen awareness of the consequences of a lifecycle approach to HTA from pre-market, market approval, post-market, and disinvestment; improve knowledge of suitable methods and processes; strengthen connections across stakeholders; and prioritize activities. Those with an interest in finding answers to these challenges will come together to make a lifecycle approach happen when HTAi 2022 Annual Meeting is held in Utrecht and virtually, June 25- 29. Learn more about the theme on the o cial HTAi 2022 Annual Meeting website. June 25-29, 2022 · www.htai2022.org · #HTAi2022Utrecht

WANT TO GET MORE INVOLVED IN A WORKING GROUP OR PROJECT? Join an HTAi Interest Group! Did you know: • HTAi has 10 different Interest Groups • 60% of HTAi members belong to one or more Interest Group • Fosters project collaboration, facilitates the exchange of information, and sets the stage for networking on small-scale initiatives through to engagement in larger, multi-stakeholder international projects Involvement in the IGs is open to all HTAi members with current membership, allowing you to keep up with IG activities and opportunities to get more involved in specific working groups and projects. Want more info? Visit https://htai.org/interest-groups

2022 LATIN AMERICA POLICY FORUM Brasília, Brazil August 14-16, 2022



1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada T5J 3N4 Tel: 780.448.4881 Fax: 780.448.0018 E-mail: [email protected] Twitter: twitter.com/HTAiOrg Facebook: facebook.com/HTAiOrg LinkedIn: linkedin.com/company/htai www.HTAi.org